Vestal Point Capital’s SpyGlass Pharma SGP Stock Holding History
Bought
Maintained
Sold
Other funds holding SGP
Vestal Point Capital's SGP Position: Q3 2026 in Review
Vestal Point Capital reduced its SpyGlass Pharma (SGP) stake by 4.5% in Q3 2026, selling an estimated $739K and leaving 640,000 shares worth $16.6M. The position accounts for 0.43% of the portfolio, ranked #31.
Vestal Point Capital first reported a position in SGP in Q1 2026 and has held it in 3 quarters since. The position peaked at $17.3M in Q1 2026. 70 funds tracked by Wall St. Rank hold SGP as of Q3 2026.
- Vestal Point Capital held 640,000 shares of SpyGlass Pharma worth $16.6M as of Q3 2026.
- Vestal Point Capital sold 30,000 SpyGlass Pharma shares in Q3 2026, an estimated $739K.
- SpyGlass Pharma made up 0.43% of Vestal Point Capital's portfolio in Q3 2026, its #31 holding.
- Vestal Point Capital first reported a position in SpyGlass Pharma in Q1 2026 and has held it in 3 quarters since.
- Vestal Point Capital's SpyGlass Pharma position peaked at $17.3M in Q1 2026.
- 70 funds tracked by Wall St. Rank held SpyGlass Pharma as of Q3 2026.
Based on Vestal Point Capital's 13F filing for Q3 2026, filed 16 Nov 2026.